us$1.8 million dept of interior grant, page-2

Notwithstanding the undoubtedly huge potential market for ReCell in cosmetic surgery, the last paragraph in the announcement seems to go beyond this.

"We are pleased to be selected as a participant in the very important Limb Salvage Program, and are confident that ReCell will deliver improved outcomes and benefits to patients and clinicians. There is huge potential for this technology in the aesthetics and plastic applications for military and civilian populations."

Limb Salvage? Is this a hint about ReCell's potential as a platform technology in the wider Regenerative Medicine space? Not just healing burns and wounds, but actually growing skin as an essential pre-requisite for Limb Salvage?

I'm liking this more and more.

Circa A$4 million revenue, A$ 3.8 mllion cash (at June 30)total US$4.2 million funding, Market cap $10 million....doesn't add up to me.